In the past week, PGEN stock has gone up by 5.33%, with a monthly gain of 6.76% and a quarterly surge of 17.04%. The volatility ratio for the week is 6.40%, and the volatility levels for the last 30 days are 9.87% for Precigen Inc The simple moving average for the past 20 days is 9.72% for PGEN’s stock, with a 28.73% simple moving average for the past 200 days.
Is It Worth Investing in Precigen Inc (NASDAQ: PGEN) Right Now?
Company’s 36-month beta value is 1.95.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for PGEN is 163.01M, and currently, short sellers hold a 15.55% ratio of that floaft. The average trading volume of PGEN on May 02, 2025 was 1.68M shares.
PGEN) stock’s latest price update
Precigen Inc (NASDAQ: PGEN)’s stock price has soared by 1.94 in relation to previous closing price of 1.55. Nevertheless, the company has seen a gain of 5.33% in its stock price over the last five trading days. prnewswire.com reported 2025-04-16 that – International event will raise awareness and bring together RRP patients, caregivers, and the healthcare community supporting them – – Recurrent respiratory papillomatosis is a rare, debilitating, chronic disease that impacts both children and adults and is mainly driven by HPV 6/11 infection – – There is no FDA-approved therapeutic for the treatment of RRP, and the current standard-of-care is repeated surgeries, which do not address the underlying cause of disease and are associated with significant morbidity and risk of irreversible injury – GERMANTOWN, Md., April 16, 2025 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the Company will team up again with the Recurrent Respiratory Papillomatosis Foundation (RRPF) to co-host the annual RRP Awareness Day on June 11, 2025.
Analysts’ Opinion of PGEN
Cantor Fitzgerald gave a rating of “Overweight” to PGEN, setting the target price at $7 in the report published on November 18th of the previous year.
PGEN Trading at -1.72% from the 50-Day Moving Average
After a stumble in the market that brought PGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.19% of loss for the given period.
Volatility was left at 9.87%, however, over the last 30 days, the volatility rate increased by 6.40%, as shares surge +19.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -19.04% lower at present.
During the last 5 trading sessions, PGEN rose by +6.33%, which changed the moving average for the period of 200-days by -15.16% in comparison to the 20-day moving average, which settled at $1.4408. In addition, Precigen Inc saw 41.07% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PGEN starting from Perez Jeffrey Thomas, who purchase 58,823 shares at the price of $0.85 back on Aug 09 ’24. After this action, Perez Jeffrey Thomas now owns 743,097 shares of Precigen Inc, valued at $50,000 using the latest closing price.
KIRK RANDAL J, the Director of Precigen Inc, purchase 23,529,411 shares at $0.85 during a trade that took place back on Aug 09 ’24, which means that KIRK RANDAL J is holding 64,547,214 shares at $19,999,999 based on the most recent closing price.
Stock Fundamentals for PGEN
Current profitability levels for the company are sitting at:
- -34.4 for the present operating margin
- -0.29 for the gross margin
The net margin for Precigen Inc stands at -32.16. The total capital return value is set at -1.09. Equity return is now at value -136.30, with -82.32 for asset returns.
Based on Precigen Inc (PGEN), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -12.39. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -22505.33.
Currently, EBITDA for the company is -123.5 million with net debt to EBITDA at 0.19. When we switch over and look at the enterprise to sales, we see a ratio of 113.08. The receivables turnover for the company is 3.37for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.76.
Conclusion
In a nutshell, Precigen Inc (PGEN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
